Paper8364906
Histologically benign or low-grade malignant tumors adjacent to high-grade ovarian carcinomas contain molecular characteristics of high-grade carcinomas.
Zheng J and 5 others. Cancer Res, 1993. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. Histologically benign or low-grade malignant tumors adjacent to high-grade ovarian carcinomas contain molecular characteristics of high-grade carcinomas. Papers, record 8364906. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8364906
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma | Major topic |
| Ovarian Neoplasms | Major topic |
| Alleles | |
| Base Sequence | |
| Chromosome Deletion | |
| Chromosomes, Human, Pair 11 | |
| Cystadenoma | |
| Female | |
| Humans | |
| Molecular Sequence Data |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R29 CA51167 | NCI NIH HHS | United States | R29CA051167 | PubMed and NIH | NIH RePORTER |
| R35 CA53890 | NCI NIH HHS | United States | R35CA053890 | PubMed and NIH | NIH RePORTER |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24234560 | Family history in ovarian cancer referral population. | J Genet Couns | 1996 | https://conductscience.org/library/papers/24234560 | PubMed |
| 21422097 | Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. | Hum Mol Genet | 2011 | https://conductscience.org/library/papers/21422097 | PubMed |
| 17519898 | Increased chromosomal stability in cultures of ovarian tumours of low malignant potential compared to cystadenomas. | Br J Cancer | 2007 | https://conductscience.org/library/papers/17519898 | PubMed |
| 16607277 | Histone modifications silence the GATA transcription factor genes in ovarian cancer. | Oncogene | 2006 | https://conductscience.org/library/papers/16607277 | PubMed |
| 15940270 | Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling. | Oncogene | 2005 | https://conductscience.org/library/papers/15940270 | PubMed |
| 9020485 | Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9020485 | PubMed |
| 8701990 | Origins of heterogeneous ovarian carcinomas. A molecular cytogenetic analysis of histologically benign, low malignant potential, and fully malignant components. | Am J Pathol | 1996 | https://conductscience.org/library/papers/8701990 | PubMed |
| 7942844 | A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1. | Am J Hum Genet | 1994 | https://conductscience.org/library/papers/7942844 | PubMed |
| 7669555 | The genetic analysis of ovarian cancer. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7669555 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8364906
GET https://conductscience.org/api/papers/v1/8364906/authors